Lin Liu

FDA Approved Drug Library Screening Identifies Robenidine as a Repositionable Antifungal

Jing-quan Li, R. Shapiro, J. Lopez-Ribot, 2020, Frontiers in Microbiology.

Repurposing the FDA‐approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species

Jing-quan Li, Yibing Peng, Jia Zhou, 2021, Microbial biotechnology.

Proscillaridin A slows the prostate cancer progression through triggering the activation of endoplasmic reticulum stress

Wei-Qiang Gao, Yanfeng Liu, Lin Liu, 2020, Cell cycle.

Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction

Wei-Qiang Gao, Yanfeng Liu, Lin Liu, 2019, Cell proliferation.

A dual action small molecule enhances azoles and overcomes resistance through co-targeting Pdr5 and Vma1: Osimertinib targets Pdr5 and Vma1.

P. Kane, Jing-quan Li, Yan-bin Zhao, 2022, Translational research : the journal of laboratory and clinical medicine.

Relationships Between Biological Heavy Metals and Breast Cancer: A Systematic Review and Meta-Analysis

Yuxuan Luo, Chang Liu, Lin Liu, 2022, Frontiers in Nutrition.